阿司匹林与口服抗凝药在膝关节置换术后静脉血栓栓塞预防中效果相当:随机对照试验的系统综述与Meta分析
该系统综述与Meta分析纳入7项随机对照试验共2323例参与者,比较阿司匹林与口服抗凝药在膝关节置换术后预防静脉血栓栓塞的效果与安全性。阿司匹林组静脉血栓栓塞的相对风险为1.29(95%CI 0.78至2.14),深静脉血栓为1.33(95%CI 0.71至2.50),肺栓塞为1.01(95%CI 0.25至4.03),两组在出血、伤口并发症或死亡率方面无显著差异。作者结论认为现有随机对照试验证据提示阿司匹林在预防静脉血栓栓塞方面与口服抗凝药同等有效且安全。
要点
- 阿司匹林组静脉血栓栓塞相对风险为1.29(95%CI 0.78至2.14),与口服抗凝药相比未达统计学显著。
- 深静脉血栓相对风险1.33(95%CI 0.71至2.50),肺栓塞相对风险1.01(95%CI 0.25至4.03)。
- 两组在出血、伤口并发症或死亡率方面未发现显著差异。
核心结论
- 现有随机对照试验证据提示阿司匹林在预防静脉血栓栓塞方面与口服抗凝药同等有效且安全。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase、Web of Science和Cochrane Library,纳入7项随机对照试验共2323例参与者,比较阿司匹林与口服抗凝药在膝关节置换术后预防静脉血栓栓塞的效果。
主要发现
- 阿司匹林组与口服抗凝药组相比,静脉血栓栓塞的相对风险为1.29(95%CI 0.78至2.14)。
- 深静脉血栓的相对风险为1.33(95%CI 0.71至2.50),肺栓塞的相对风险为1.01(95%CI 0.25至4.03)。
- 两组在出血、伤口并发症或死亡率方面未发现显著差异。
- 基于地区、发表年份、静脉血栓栓塞类型、静脉血栓栓塞事件数、阿司匹林剂量、对照类型、机械性血栓预防使用、试验质量及研究资助等因素的亚组分析显示两组静脉血栓栓塞发生率无显著差异。
- 静脉血栓栓塞和深静脉血栓结局的总体证据质量评为中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of our study was to assess the effectiveness and safety of aspirin for venous thromboembolism (VTE) prophylaxis after knee arthroplasty. METHODS: The review process was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. There were two independent researchers who conducted literature searches based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses. PubMed, Embase, Web of Science, and the Cochrane Library were searched for studies comparing aspirin and oral anticoagulants (OACs) for VTE prophylaxis after knee arthroplasty. Our meta-analysis included seven randomized controlled trials with 2,323 participants. RESULTS: The relative risk (RR) of VTE following knee arthroplasty was 1.29 (95% confidence interval [CI], 0.78 to 2.14) when comparing aspirin to OACs. Similar results were observed for deep vein thrombosis (RR, 1.33; 95% CI, 0.71 to 2.50) and pulmonary embolism (RR, 1.01; 95% CI, 0.25 to 4.03). No notable differences were found in bleeding, wound complications, or mortality between two groups. Analyses of subgroups based on factors like region, publication year, VTE type, VTE events, aspirin dose, comparator types, use of mechanical thrombosis prophylaxis, trial quality, and study support revealed no substantial differences in VTE incidence between two groups. Overall, the quality of evidence for VTE and deep vein thrombosis outcomes was moderate. CONCLUSIONS: Existing randomized controlled trial evidence suggests that aspirin is equally effective and safe as OACs in preventing VTE.
引用
- Ren Y, Peng JB, Su YW, et al. Aspirin Is as Effective as Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Knee Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Arthroplasty. 2025. PMID: 40015383. doi:10.1016/j.arth.2025.02.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。